Hasil Pencarian - Bruno Fautrel
- Menampilkan 1 - 20 hasil dari 29
- Ke Halaman Berikutnya
-
1
Anti-Interleukin-1 Agents in Adult Onset Still's Disease oleh Cecilia Giampietro, Bruno Fautrel
Diterbitkan 2012-01-01Dapatkan teks lengkap
Artikel -
2
Adult Onset Still's Disease and Autoinflammation oleh Petros Efthimiou, L. Nandini Moorthy, Clio P. Mavragani, Dimitris Skokos, Bruno Fautrel
Diterbitkan 2012-01-01Dapatkan teks lengkap
Artikel -
3
-
4
-
5
-
6
Risk of cancer for patients with rheumatoid arthritis versus general population: a national claims database cohort studyResearch in context oleh Maxime Beydon, Sandrine Pinto, Yann De Rycke, Bruno Fautrel, Xavier Mariette, Raphaèle Seror, Florence Tubach
Diterbitkan 2023-12-01Dapatkan teks lengkap
Artikel -
7
-
8
Predictors of good response to conventional synthetic DMARDs in early seronegative rheumatoid arthritis: data from the ESPOIR cohort oleh Cédric Lukas, Julia Mary, Michel Debandt, Claire Daïen, Jacques Morel, Alain Cantagrel, Bruno Fautrel, Bernard Combe
Diterbitkan 2019-11-01Dapatkan teks lengkap
Artikel -
9
Risk of malignancy in rheumatoid arthritis patients initiating biologics: an historical propensity score matched cohort study within the French nationwide healthcare database oleh Bruno Fautrel, Xavier Mariette, Yann De Rycke, Florence Tubach, Johann castaneda, Raphaele Seror, Sandrine Pinto, Alexandre Lafourcade
Diterbitkan 2022-11-01Dapatkan teks lengkap
Artikel -
10
Suboptimal management of rheumatoid arthritis in France: a real-world study based on data from the French National Health Data System oleh Bruno Fautrel, Jean-François Bergmann, Cécile Gaujoux-Viala, Stève Bénard, Mélanie Goguillot, Asma Mélaine, Marie Guérin, Alban Edouard
Diterbitkan 2023-10-01Dapatkan teks lengkap
Artikel -
11
PERFUSE: a French non-interventional study of patients with inflammatory bowel disease receiving infliximab biosimilar SB2: a 12-month analysis oleh Yoram Bouhnik, Bruno Fautrel, Laurent Beaugerie, Anne-Laure Pelletier, Christine Martinez-Vinson, Ulrich Freudensprung, Amira Brigui, Janet Addison
Diterbitkan 2023-03-01Dapatkan teks lengkap
Artikel -
12
Machine learning predicts response to TNF inhibitors in rheumatoid arthritis: results on the ESPOIR and ABIRISK cohorts oleh Bruno Fautrel, Francis Guillemin, Samuel Bitoun, Xavier Mariette, Philippe Broët, Marc Pallardy, Vincent Bouget, Julien Duquesne, Signe Hassler, Paul-Henry Cournède
Diterbitkan 2022-08-01Dapatkan teks lengkap
Artikel -
13
Similar alteration for mental and physical aspects in health-related quality of life over 5 to 8 years in 1347 patients with early arthritis and early inflammatory back pain oleh Déborah Puyraimond-Zemmour, Benjamin Granger, Anna Molto, Cécile Gaujoux-Viala, Francis Guillemin, Adeline Ruyssen-Witrand, Maxime Dougados, Bruno Fautrel, Laure Gossec
Diterbitkan 2019-02-01Dapatkan teks lengkap
Artikel -
14
Evolution of direct costs in the first years of rheumatoid arthritis: impact of early versus late biologic initiation--an economic analysis based on the ESPOIR cohort. oleh Karine Chevreul, Georges Haour, Sandy Lucier, Stephanie Harvard, Marie-Laure Laroche, Xavier Mariette, Alain Saraux, Isabelle Durand-Zaleski, Francis Guillemin, Bruno Fautrel
Diterbitkan 2014-01-01Dapatkan teks lengkap
Artikel -
15
Severe glandular tularemia in a patient treated with anti-tumour necrosis factor for psoriatic arthritis oleh Ruxandra Calin, Eric Caumes, Florence Reibel, Anzime Ali Mohamed, Florence Brossier, Violaine Foltz, Samia Boussouar, Bruno Fautrel, Max Maurin, Christine Katlama, Valérie Pourcher
Diterbitkan 2017-07-01Dapatkan teks lengkap
Artikel -
16
Influence of perceived barriers and facilitators for physical activity on physical activity levels in patients with rheumatoid arthritis or spondyloarthritis: a cross-sectional stu... oleh Thomas Davergne, Rawdha Tekaya, Jérémie Sellam, Anne Tournadre, Stéphane Mitrovic, Adeline Ruyssen-Witrand, Christophe Hudry, Sabrina Dadoun, Jérôme Avouac, Bruno Fautrel, Laure Gossec
Diterbitkan 2021-10-01Dapatkan teks lengkap
Artikel -
17
Adult-onset Still’s disease biological treatment strategy may depend on the phenotypic dichotomy oleh François Vercruysse, Thomas Barnetche, Estibaliz Lazaro, Emilie Shipley, François Lifermann, Alexandre Balageas, Xavier Delbrel, Bruno Fautrel, Christophe Richez, Thierry Schaeverbeke, Marie-Elise Truchetet
Diterbitkan 2019-02-01Dapatkan teks lengkap
Artikel -
18
Comparative Effectiveness, Time to Discontinuation, and Patient-Reported Outcomes with Baricitinib in Rheumatoid Arthritis: 2-Year Data from the Multinational, Prospective Observat... oleh Rieke Alten, Gerd R. Burmester, Marco Matucci-Cerinic, Jean-Hugues Salmon, Andrew Östör, Khai Jing Ng, Jens Gerwien, Liliana Zaremba-Pechmann, Alan J. M. Brnabic, Bruno Fautrel
Diterbitkan 2023-09-01Dapatkan teks lengkap
Artikel -
19
Treat-to-target in rheumatoid arthritis: a real-world study of the application and impact of treat-to-target within the wider context of patient management, patient centricity and... oleh Bruno Fautrel, Rieke Alten, Yves Piette, Roberto Caporali, Susana Romero-Yuste, Jasper Broen, Katrien Van Beneden, Martin Welcker, Peter C. Taylor, Oliver Howell, Elke Rottier, Monia Zignani
Diterbitkan 2022-12-01Dapatkan teks lengkap
Artikel -
20
The RA-BE-REAL Multinational, Prospective, Observational Study in Patients with Rheumatoid Arthritis Receiving Baricitinib, Targeted Synthetic, or Biologic Disease-Modifying Therap... oleh Rieke Alten, Gerd R. Burmester, Marco Matucci-Cerinic, Jean-Hugues Salmon, Pedro Lopez-Romero, Walid Fakhouri, Inmaculada de la Torre, Liliana Zaremba-Pechmann, Thorsten Holzkämper, Bruno Fautrel
Diterbitkan 2022-10-01Dapatkan teks lengkap
Artikel